AGX

SEC source: 0001104659-21-056553 · tm2114480-1_4seq1.xml · nonDerivative · entry 1

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,631

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 26, 2021, the Reporting Person exercised her stock option received on December 23, 2019 to purchase 2,631 shares of the Issuer's common stock at a price of $40.15 per share.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

F2 · shares: On April 20, 2021, the Reporting Person sold 12,248 shares of the Issuer's common stock on the open market at an average price of $52.69 per share.

SEC source: 0001104659-21-053839 · tm2113788-1_4seq1.xml · nonDerivative · entry 1

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Through MITENCO LLC

Disclosed balance after: 13,333

F1 · shares: On April 20, 2021, MITENCO LLC, an entity controlled by the Reporting Person, sold 15,000 shares of the Issuer's Common stock in the open market at an average price of $52.60 per share.

F2 · ownership.nature: Previously, these shares were directly owned by the Reporting Person. The shares were subsequently contributed to MITENCO, LLC.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,748

F1 · shares: On April 19, 2021, the Reporting Person sold 939 shares of the Issuer's common stock on the open market at an average price of $54.18 per share. As disclosed in the Reporting Person's Form 4 filed on April 13, 2021, the primary purpose for selling these shares (and those associated with footnote 2) related to the payment of taxes associated with the vesting of shares on April 9, 2021.

SEC source: 0001104659-21-052673 · tm2113525-4_4seq1.xml · derivative · entry 3

Deily Richard H · CIK 0001358787 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 3,500 shares

Expires not disclosed

F4 · shares: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F4 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F4 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

SEC source: 0001104659-21-052673 · tm2113525-4_4seq1.xml · derivative · entry 2

Deily Richard H · CIK 0001358787 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,500

Underlying: Common Stock · 3,500 shares

Expires 2031-04-16

F1 · shares: On April 16, 2021, the Reporting Person received 10-year options to purchase 3,500 shares of the Issuer's common stock with an exercise price of $54.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/16/2022.

F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029;

F3 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; and (f) options to acquire 3,500 shares of common stock at a price of $54.60 per share with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031. Options identified in subjects (c), (d), (e) and (f) are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · derivative · entry 5

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F8 · shares: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F8 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F8 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F6 · shares: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F7 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 12, 2019; (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2020; and (c) a target number of 10,000 shares of PBRSUs granted on April 16, 2021, all to vest in their entirety at the end of a three-year performance period as generally reported under footnote 6 above.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,000

Underlying: Common Stock · 10,000 shares

Expires 2031-04-16

F3 · shares: On April 16, 2021, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $54.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/16/2022.

F4 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F5 · balance_after: and (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030, and (f) options to acquire 10,000 shares of common stock at a price of $54.60 with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, all subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-21-052573 · tm2113525-3_4seq1.xml · derivative · entry 3

trebilcock Terrance Colin · CIK 0001791304 · Co-President, Gemma Power Sys

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F3 · shares: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F3 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F3 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

SEC source: 0001104659-21-052573 · tm2113525-3_4seq1.xml · derivative · entry 2

trebilcock Terrance Colin · CIK 0001791304 · Co-President, Gemma Power Sys

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F2 · shares: On April 16, 2021, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 5,000 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,000 shares and a cumulative total at the end of the three-year performance period with a target number of 2,000 shares. The awards will be more fully described in the Issuer's 2021 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 5,000 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,000 shares and a cumulative total at the end of the three-year performance period with a target number of 2,000 shares. The awards will be more fully described in the Issuer's 2021 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 5,000 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,000 shares and a cumulative total at the end of the three-year performance period with a target number of 2,000 shares. The awards will be more fully described in the Issuer's 2021 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001104659-21-052573 · tm2113525-3_4seq1.xml · derivative · entry 1

trebilcock Terrance Colin · CIK 0001791304 · Co-President, Gemma Power Sys

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · shares: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F1 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F1 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

SEC source: 0001104659-21-052570 · tm2113525-2_4seq1.xml · derivative · entry 3

Collins Charles Edwin IV · CIK 0001791800 · Co-President, Gemma Power Sys

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F3 · shares: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F3 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F3 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

SEC source: 0001104659-21-052570 · tm2113525-2_4seq1.xml · derivative · entry 2

Collins Charles Edwin IV · CIK 0001791800 · Co-President, Gemma Power Sys

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F2 · shares: On April 16, 2021, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 5,000 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,000 shares and a cumulative total at the end of the three-year performance period with a target number of 2,000 shares. The awards will be more fully described in the Issuer's 2021 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 5,000 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,000 shares and a cumulative total at the end of the three-year performance period with a target number of 2,000 shares. The awards will be more fully described in the Issuer's 2021 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 5,000 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,000 shares and a cumulative total at the end of the three-year performance period with a target number of 2,000 shares. The awards will be more fully described in the Issuer's 2021 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001104659-21-052570 · tm2113525-2_4seq1.xml · derivative · entry 1

Collins Charles Edwin IV · CIK 0001791800 · Co-President, Gemma Power Sys

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · shares: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F1 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F1 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

SEC source: 0001104659-21-052567 · tm2113525-1_4seq1.xml · derivative · entry 4

BOSSELMANN RAINER H · CIK 0001028546 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F7 · shares: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F7 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F7 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

SEC source: 0001104659-21-052567 · tm2113525-1_4seq1.xml · derivative · entry 3

BOSSELMANN RAINER H · CIK 0001028546 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F5 · shares: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 12,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F5 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 12,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F5 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 12,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 12, 2019; (b) a target number of 12,500 shares of PBRSUs granted on April 16, 2020; and (c) a target number of 12,500 shares of PBRSUs granted on April 16, 2021, all to vest in their entirety at the end of a three-year performance period as generally reported under footnote 5 above.

SEC source: 0001104659-21-052567 · tm2113525-1_4seq1.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 10,000 shares

Expires 2031-04-16

F2 · shares: On April 16, 2021, the Reporting Person received 10-year options to purchase 12,500 shares of the Issuer's common stock with an exercise price of $54.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/16/2022.

F3 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 25,000 shares of common stock at a price of $16.37 per share with Date Exercisable of 03/07/2014 and Expiration Date of 03/07/2023; (b) options to acquire 50,000 shares of common stock at a price of $32.68 with Date Exercisable of 04/16/2016 and Expiration Date of 04/16/2025; (c) options to acquire 50,000 shares of common stock at a price of $33.85 per share with Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (d) options to acquire 50,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (e) options to acquire 40,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028;

F4 · balance_after: (f) options to acquire 40,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029; (g) options to acquire 40,000 shares of common stock at a price of $33.81 per share with Date Exercisable 4/16/2021 and Expiration Date of 4/16/2030; and (h) options to acquire 12,500 shares of common stock at a price of $54.60 with Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-21-049838 · tm2112892-2_4seq1.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F1 · derivative.exercise_date: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F1 · derivative.expiration_date: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F3 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 12, 2019 and; (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2020, all to vest in their entirety at the end of a three-year performance period.

SEC source: 0001104659-21-049838 · tm2112892-2_4seq1.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,687

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F2 · balance_after: Assuming the trading window opens shortly after the year end financials are released, the Reporting Person intends to sell a portion of these shares primarily for the purposes of paying taxes related to the vesting of these shares.

SEC source: 0001104659-21-049835 · tm2112892-1_4seq1.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 22,484 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 10,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F1 · derivative.exercise_date: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 22,484 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 10,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F1 · derivative.expiration_date: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 22,484 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 10,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F3 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 12, 2019 and; (b) a target number of 12,500 shares of PBRSUs granted on April 16, 2020, all to vest in their entirety at the end of a three-year performance period.

SEC source: 0001104659-21-049835 · tm2112892-1_4seq1.xml · nonDerivative · entry 1

BOSSELMANN RAINER H · CIK 0001028546 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 22,484 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 10,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F2 · balance_after: 2,241 shares are held by Rainer and Beverley Bosselmann, as joint tenants, and the remaining shares are held directly by Rainer Bosselmann.

SEC source: 0001104659-20-136307 · tm2038593d7_4seq1.xml · derivative · entry 4

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,000

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock at an exercise price of $45.75. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; and

F3 · balance_after: (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-136301 · tm2038593d5_4seq1.xml · derivative · entry 2

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 of the Issuer's Common Stock at an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $26.88 with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028;

F3 · balance_after: (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-136303 · tm2038593d6_4seq1.xml · derivative · entry 1

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $42.31 per share with initial Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (b) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (c) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-136300 · tm2038593d4_4seq1.xml · derivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,000

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2021.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028;

F3 · balance_after: (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-136295 · tm2038593-3_4seq1.xml · derivative · entry 2

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's Common stock at an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with initial Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and

F3 · balance_after: (e) 10,00 shares of common stock at a price of $45.75 per share with initial Date Exercisable 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-136293 · tm2038593-2_4seq1.xml · derivative · entry 4

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning 12/14/2021.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of Common Stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027;

F3 · balance_after: (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; and (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-136289 · tm2038593-1_4seq1.xml · derivative · entry 3

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,667

Underlying: Common Stock · 10,000 shares

Expires 2030-12-14

F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's Common stock at a price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning 12/14/2021.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with an initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-113560 · a4.xml · nonDerivative · entry 3

Griffin William F Jr · CIK 0001384123 · Director · Gemma, Non-Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 211,150

F3 · shares: On October 7, 2020, the Reporting Person sold 24,692 shares of the Issuer's common stock on the open market at an average price of $44.47 per share.

SEC source: 0001104659-20-113560 · a4.xml · nonDerivative · entry 2

Griffin William F Jr · CIK 0001384123 · Director · Gemma, Non-Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 235,842

F2 · shares: On October 6, 2020, the Reporting Person sold 17,743 shares of the Issuer's common stock on the open market at an average price of $44.39 per share.

SEC source: 0001104659-20-113560 · a4.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · Gemma, Non-Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 253,585

F1 · shares: On October 5, 2020, the Reporting Person sold 11,134 shares of the Issuer's common stock on the open market at an average price of $44.11 per share.

SEC source: 0001104659-20-111700 · a4.xml · nonDerivative · entry 1

Deily Richard H · CIK 0001358787 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

F1 · shares: On October 2, 2020, the Reporting Person purchased 250 shares of the Issuer's common stock on the open market at a price of $42.02 per share.

SEC source: 0001104659-20-109336 · a4.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · Gemma, Non-Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 264,719

F1 · shares: On September 22, 2020, the Reporting Person sold 300 shares of the Issuer's common stock on the open market at an average price of $46.06 per share.

SEC source: 0001104659-20-107439 · a4.xml · nonDerivative · entry 2

Griffin William F Jr · CIK 0001384123 · Director · Non-Exec. Chairman of Gemma

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 265,019

F2 · shares: On September 18, 2020, the Reporting Person sold 17,131 shares of the Issuer's common stock on the open market at an average price of $44.92 per share.

SEC source: 0001104659-20-107439 · a4.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · Non-Exec. Chairman of Gemma

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 282,150

F1 · shares: On September 17, 2020, the Reporting Person sold 4,000 shares of the Issuer's common stock on the open market at an average price of $46.63 per share.

SEC source: 0001104659-20-085263 · a4.xml · derivative · entry 4

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 10,000 shares

Expires 2022-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On July 20, 2020, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share.

F1 · derivative.underlying_shares: On July 20, 2020, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share.

F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire; (a) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027;

F3 · balance_after: (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a purchase price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028; and (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029.

SEC source: 0001104659-20-085263 · a4.xml · nonDerivative · entry 1

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On July 20, 2020, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share.

SEC source: 0001104659-20-048745 · a4.xml · nonDerivative · entry 1

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

SEC source: 0001104659-20-048748 · a4.xml · derivative · entry 2

Deily Richard H · CIK 0001358787 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 10,000 shares

Expires 2030-04-16

F1 · shares: On April 16, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $33.81per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/16/2021.

F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029 and;

F3 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030. Options identified in subjects (c), (d) and (e) are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-048746 · a4.xml · derivative · entry 3

BOSSELMANN RAINER H · CIK 0001028546 · Director · Chairman of the Board & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F5 · shares: On April 16, 2020, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 12,500 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2020 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR.

F6 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 5 above.

F6 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 5 above.

F7 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 13, 2018; (b) a target number of 10,000 shares of PBRSUs granted on April 12, 2019; and (c) a target number of 12,500 shares of PBRSUs granted on April 16, 2020, all to vest in their entirety at the end of a three-year performance period as reported under footnote 5 above.

SEC source: 0001104659-20-048746 · a4.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · Director · Chairman of the Board & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,000

Underlying: Common Stock · 40,000 shares

Expires 2030-04-16

F2 · shares: On April 16, 2020, the Reporting Person received 10-year options to purchase 40,000 shares of the Issuer's common stock with an exercise price of $33.81 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/16/2021.

F3 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 25,000 shares of common stock at a price of $16.37 per share with Date Exercisable of 03/07/2014 and Expiration Date of 03/07/2023; (b) options to acquire 50,000 shares of common stock at a price of $32.68 with Date Exercisable of 04/16/2016 and Expiration Date of 04/16/2025; (c) options to acquire 50,000 shares of common stock at a price of $33.85 per share with Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (d) options to acquire 50,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (e) options to acquire 40,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028;

F4 · balance_after: (f) options to acquire 40,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029 and (g) options to acquire 40,000 shares of common stock at a price of $33.81 per share with Date Exercisable 4/16/2021 and Expiration Date of 4/16/2030 all of which are subject to the aforementioned three-year ratably vesting schedule

SEC source: 0001104659-20-048744 · a4.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F4 · shares: On April 16, 2020, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2020 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR.

F5 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

F5 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

F6 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 13, 2018; (b) a target number of 8,000 shares of PBRSUs granted on April 12, 2019 and; (c) a target number of 10,000 shares of PBRSUs granted on April 16, 2020, all to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

SEC source: 0001104659-20-048744 · a4.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,000

Underlying: Common Stock · 32,000 shares

Expires 2030-04-16

F1 · shares: On April 16, 2020, the Reporting Person received 10-year options to purchase 32,000 shares of the Issuer's common stock with an exercise price of $33.81 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/16/2021.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F3 · balance_after: and (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030, all subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-20-048743 · a4.xml · derivative · entry 1

trebilcock Terrance Colin · CIK 0001791304 · Co-President, Gemma Power Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 10,000 shares

Expires 2030-04-16

F1 · shares: On April 16, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $33.81 per share. The options will vest ratably over three year on each anniversary of the grant date starting from 4/16/2021.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 5,000 shares of common stock at a price of $46.35 with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (b) options to acquire 25,000 shares of common stock at a price of $43.10 with Date Exercisable of 9/12/2019 and Expiration Date of 9/12/2028; (c) options to acquire 10,000 shares of common stock at a price of $42.31 with Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029 and; (d) options to acquire 10,000 shares of common stock at a price of $33.81 with Date Exercisable on 4/16/2021 and Expiration Date 4/16/2030, all of which will vest ratably over three years from their respective grant date.

SEC source: 0001104659-20-048742 · a4.xml · derivative · entry 1

Collins Charles Edwin IV · CIK 0001791800 · Co-President, Gemma Power Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 10,000 shares

Expires 2030-04-16

F1 · shares: On April 16, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $33.81 per share. The options will vest ratably over three year on each anniversary of the grant date starting from 4/16/2021.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 5,000 shares of common stock at a price of $46.35 with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (b) options to acquire 25,000 shares of common stock at a price of $43.10 with Date Exercisable of 9/12/2019 and Expiration Date of 9/12/2028; (c) options to acquire 10,000 shares of common stock at a price of $42.31 with Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029 and; (d) options to acquire 10,000 shares of common stock at a price of $33.81 with Date Exercisable on 4/16/2021 and Expiration Date 4/16/2030, all of which will vest ratably over three years from their respective grant date.

SEC source: 0001104659-19-076014 · a4.xml · derivative · entry 2

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028;

F3 · balance_after: (f) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; and (g) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable beginning 12/23/2020 and Expiration Date of 12/23/2029.

SEC source: 0001104659-19-075976 · a4.xml · derivative · entry 3

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,667

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration date of 12/12/2028; and (d) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable beginning on 12/23/2020 and Expiration Date of 12/23/2029.

SEC source: 0001104659-19-075970 · a4.xml · derivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,000

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028;

F3 · balance_after: (f) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028; and (g) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029.

SEC source: 0001104659-19-075973 · a4.xml · derivative · entry 2

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (c) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028 and (d) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029.